Predict your next investment

InnovHeart company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
innovheart.com

See what CB Insights has to offer

Founded Year

2015

Stage

Series B | Alive

Total Raised

$23.57M

Last Raised

$23.57M | 1 yr ago

About InnovHeart

InnovHeart develops novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease.

InnovHeart Headquarter Location

Via Giovannino de Grassi 11

Milano, 20123,

Italy

+39 0236515110

Latest InnovHeart News

Azin Parhizgar, Ph.D. Joins InnovHeart as Independent Member of the Board of Directors

Jan 12, 2021

as an Independent Member of the Board of Directors. Dr. Parhizgar is currently the Chairman of CVPath Institute, Inc. a Senior Venture Partner at 415 Capital, and a Board member at Soundbite Medical Solutions Inc. and MGVS (Vassl). She was the Chief Executive Officer, President and Board Member at Claret Medical, an embolic protection device company acquired by Boston Scientific Corp. in 2018. Prior to Claret Medical, Dr. Parhizgar served as the Chief Operating Officer of Conor Medsystems, which led to the acquisition of the company by Johnson & Johnson, Inc. in 2007. Between 1996-2000 she held the position of Executive Vice President for Arterial Vascular Engineering (AVE), which was acquired by Medtronic, Inc. in 2000. Dr. Parhizgar has served as an advisor to numerous emerging medical technology companies, including several Board of Director and Scientific Advisory Board positions. Azin received both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University and continues to serve as an Advisory Board Member to the Brown University School of BioEngineering. "It is an honor for us that Dr. Parhizgar has chosen to join our Board of Directors," said Brent Ratz, Chief Executive Officer of InnovHeart. "Azin brings an incredible range of medical device and entrepreneurial experience to InnovHeart. Having led numerous cardiovascular start-ups through multiple successful acquisitions, she understands what it takes to build real value in this space. Now that InnovHeart has demonstrated successful trans-septal delivery of our Saturn implant in animals, I am excited to have Azin's insights and strategic contributions as we generate additional clinical data and advance the development of our Trans-Septal delivery system. "  "I have watched the transcatheter mitral space develop over the past several years and it is clear that there is a need for a robust and effective replacement solution for this complex disease state," noted Dr. Parhizgar. "InnovHeart has developed a compelling and differentiated technology with its Saturn TMVR system, and I am very much looking forward to joining this talented team to support the company's continued success and value creation." "I have followed Azin's accomplished career for the last 20 years. Her contributions as an Independent Director of InnovHeart will be many, and it comes at a particularly exciting time in the development of the company", added Dr. Keith D. Dawkins M.D., Chairman of InnovHeart. "With more than 3 months of positive follow-up from our first human Trans-Apical implant, and the Trans-Septal solution well underway utilizing the same Saturn valve, InnovHeart is entering a new phase. Azin's experience will augment the strong InnovHeart team focused on developing a unique TMVR solution that will enhance patient care.'' Caution: The Saturn TMVR system is limited to investigational use and is not commercially available. About InnovHeart InnovHeart s.r.l, with locations in Milan, Italy, and Newton, Mass., USA, develops Transcatheter Mitral Valve Replacement systems (TMVR) to treat patients suffering from mitral valve disease. The company is conducting clinical trials of its novel Saturn TMVR system. Saturn is a low-profile mitral heart valve designed for trans-apical or trans-septal delivery. View original content to download multimedia: http://www.prnewswire.com/news-releases/azin-parhizgar-phd-joins-innovheart-as-independent-member-of-the-board-of-directors-301205912.html SOURCE InnovHeart

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing InnovHeart

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

InnovHeart is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,891 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

InnovHeart Patents

InnovHeart has filed 4 patents.

The 3 most popular patent topics include:

  • Cardiac anatomy
  • Cardiac surgery
  • Cardiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/4/2015

9/21/2021

Cardiac anatomy, Cardiac surgery, Cardiology, Congenital heart defects, Implants (medicine)

Grant

Application Date

2/4/2015

Grant Date

9/21/2021

Title

Related Topics

Cardiac anatomy, Cardiac surgery, Cardiology, Congenital heart defects, Implants (medicine)

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.